180 related articles for article (PubMed ID: 30075439)
1. Heparanase inhibition attenuates atherosclerosis progression and liver steatosis in E
Muhammad RS; Abu-Saleh N; Kinaneh S; Agbaria M; Sabo E; Grajeda-Iglesias C; Volkova N; Hamoud S
Atherosclerosis; 2018 Sep; 276():155-162. PubMed ID: 30075439
[TBL] [Abstract][Full Text] [Related]
2. Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout Mice.
Hamoud S; Shekh Muhammad R; Abu-Saleh N; Hassan A; Zohar Y; Hayek T
Biomed Res Int; 2017; 2017():7357495. PubMed ID: 29226146
[TBL] [Abstract][Full Text] [Related]
3. Heparanase Inhibition Prevents Liver Steatosis in E
Kinaneh S; Hijaze W; Mansour-Wattad L; Hammoud R; Zaidani H; Kabala A; Hamoud S
J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329997
[TBL] [Abstract][Full Text] [Related]
4. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
Liu J; Wang Q; Wei Y; Zhang S; Chai E; Tang F
Microvasc Res; 2022 Mar; 140():104276. PubMed ID: 34742813
[TBL] [Abstract][Full Text] [Related]
5. Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.
Nguyen TK; Paone S; Baxter AA; Mayfosh AJ; Phan TK; Chan E; Peter K; Poon IKH; Thomas SR; Hulett MD
Atherosclerosis; 2024 May; 392():117519. PubMed ID: 38581737
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
[TBL] [Abstract][Full Text] [Related]
7. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE
Qian L; Ma L; Wu G; Yu Q; Lin H; Ying Q; Wen D; Gao C
Vascul Pharmacol; 2017 Feb; 89():49-57. PubMed ID: 28069546
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.
Hoekstra M; Nahon JE; de Jong LM; Kröner MJ; de Leeuw LR; Van Eck M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1402-1409. PubMed ID: 30776415
[TBL] [Abstract][Full Text] [Related]
10. Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Nasiri-Ansari Ν; Dimitriadis GK; Agrogiannis G; Perrea D; Kostakis ID; Kaltsas G; Papavassiliou AG; Randeva HS; Kassi E
Cardiovasc Diabetol; 2018 Jul; 17(1):106. PubMed ID: 30049285
[TBL] [Abstract][Full Text] [Related]
11. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
14. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
[TBL] [Abstract][Full Text] [Related]
15. Danhong Injection Attenuates High-Fat-Induced Atherosclerosis and Macrophage Lipid Accumulation by Regulating the PI3K/AKT Insulin Pathway.
Zhou M; Ren P; Li S; Kang Q; Zhang Y; Liu W; Shang J; Gong Y; Liu H
J Cardiovasc Pharmacol; 2019 Aug; 74(2):152-161. PubMed ID: 31306371
[TBL] [Abstract][Full Text] [Related]
16. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
[TBL] [Abstract][Full Text] [Related]
17. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
[TBL] [Abstract][Full Text] [Related]
19. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
[TBL] [Abstract][Full Text] [Related]
20. Reduction of mouse atherosclerosis by urokinase inhibition or with a limited-spectrum matrix metalloproteinase inhibitor.
Hu JH; Touch P; Zhang J; Wei H; Liu S; Lund IK; Høyer-Hansen G; Dichek DA
Cardiovasc Res; 2015 Mar; 105(3):372-82. PubMed ID: 25616415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]